Cargando…
Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739719/ https://www.ncbi.nlm.nih.gov/pubmed/29290934 http://dx.doi.org/10.18632/oncotarget.22579 |
| _version_ | 1783287923923222528 |
|---|---|
| author | Brüstle, Karina Heidecker, Bettina |
| author_facet | Brüstle, Karina Heidecker, Bettina |
| author_sort | Brüstle, Karina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5739719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57397192017-12-29 Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer Brüstle, Karina Heidecker, Bettina Oncotarget Editorial Impact Journals LLC 2017-11-21 /pmc/articles/PMC5739719/ /pubmed/29290934 http://dx.doi.org/10.18632/oncotarget.22579 Text en Copyright: © 2017 Brüstle et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Brüstle, Karina Heidecker, Bettina Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title | Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title_full | Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title_fullStr | Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title_full_unstemmed | Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title_short | Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| title_sort | checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739719/ https://www.ncbi.nlm.nih.gov/pubmed/29290934 http://dx.doi.org/10.18632/oncotarget.22579 |
| work_keys_str_mv | AT brustlekarina checkpointinhibitorinducedcardiotoxicitymanagingthedrawbacksofournewestagentsagainstcancer AT heideckerbettina checkpointinhibitorinducedcardiotoxicitymanagingthedrawbacksofournewestagentsagainstcancer |